alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › longitudinal-early-onset

longitudinal-early-onset

2 studies tagged longitudinal-early-onset, dated 2021-05-21 to 2023-09-10. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS) 2023-09-10
  2. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology 2021-05-21

Studies

2 studies carry this tag.

Date range

2021 to 2023

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-09-10 Brain scans and imaging

    LEADS data emphasizes the importance of biomarkers to enhance diagnostic accuracy in EOAD.

  2. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-05-21 Brain scans and imaging

    Patients with early-onset Alzheimer's disease (EOAD) are commonly excluded from large-scale observational and therapeutic studies due to their young age, atypical presentation, or absence of pathogenic mutations.

All topic tags with their study counts